Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Pharming (PHAR) over the last 5 years, with Q3 2025 value amounting to 0.03%.

  • Pharming's Return on Capital Employed rose 1400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.02% for FY2024, which is 100.0% down from last year.
  • Per Pharming's latest filing, its Return on Capital Employed stood at 0.03% for Q3 2025, which was up 1400.0% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, Pharming's Return on Capital Employed peaked at 0.17% during Q3 2021, and registered a low of 41.3% during Q1 2022.
  • Over the past 5 years, Pharming's median Return on Capital Employed value was 0.02% (recorded in 2025), while the average stood at 2.45%.
  • In the last 5 years, Pharming's Return on Capital Employed tumbled by -1700bps in 2022 and then surged by 1400bps in 2025.
  • Pharming's Return on Capital Employed (Quarter) stood at 0.05% in 2021, then tumbled by -100bps to 0.0% in 2022, then crashed by -57889bps to 0.06% in 2023, then plummeted by -100bps to 0.12% in 2024, then skyrocketed by 125bps to 0.03% in 2025.
  • Its Return on Capital Employed was 0.03% in Q3 2025, compared to 0.02% in Q2 2025 and 0.1% in Q1 2025.